De�novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis-Reference-Cited by-同舟云学术

De�novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis

Published:2020-01-30 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhang Li¹,Li Zhijun¹,Zhang Jie¹,Wu Yansheng²,Zhu Yuying¹,Tong Zhongsheng¹

Affiliation:

1. Department of Breast Oncology, Key Laboratory of Breast Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China

2. Department of Maxillofacial and Otorhinolaryngology, Head and Neck Surgery, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast surgery for patients with de novo metastatic breast cancer: A meta-analysis of randomized controlled trials;European Journal of Surgical Oncology;2024-01

2. Research Progress of Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer;Advances in Clinical Medicine;2024

3. Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer;Seminars in Oncology Nursing;2023-12

4. The Association between ER, PR, HER2, and ER−/PR+ Expression and Lung Cancer Subsequent in Breast Cancer Patients: A Retrospective Cohort Study Based on SEER Database;The Breast Journal;2023-11-11

5. Relationship Between Metabolic Activity, Cellularity, Histopathological Features of Primary Tumors and Distant Metastatic Potential in Breast Cancer;Molecular Imaging and Radionuclide Therapy;2023-10-01